The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 06, 2019

Filed:

Dec. 07, 2015
Applicant:

Immunext, Inc., Lebanon, NH (US);

Inventors:

Michael Molloy, Enfield, NH (US);

Yalin Guo, Hanover, NH (US);

Jay Rothstein, Norwich, VT (US);

Michael Rosenzweig, Boston, MA (US);

Assignee:

IMMUNEXT, INC., Lebanon, NH (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 39/395 (2006.01); C07K 16/42 (2006.01); C07K 14/705 (2006.01); C12N 15/113 (2010.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/42 (2013.01); C07K 14/70503 (2013.01); C07K 16/2803 (2013.01); C07K 16/2827 (2013.01); C12N 15/1138 (2013.01); A61K 2039/505 (2013.01); C07K 2317/73 (2013.01); C07K 2317/76 (2013.01); C07K 2319/30 (2013.01); C12N 2310/14 (2013.01); C12N 2310/531 (2013.01);
Abstract

The receptor for VISTA is identified (VSIG8) as well as the use of this receptor in the identification or synthesis of agonist or antagonist compounds, preferably antibodies, polypeptides and fusion proteins which agonize or antagonize the effects of VSIG8 and/or VISTA and/or the VSIG8/VISTA binding interaction. These antagonists may be used to suppress VISTA's suppressive effects on T cell immunity, and more particularly used in the treatment of cancer, or infectious disease. These agonist compounds may be used to potentiate or enhance VISTA's suppressive effects on T cell immunity and thereby suppress T cell immunity, such as in the treatment of autoimmunity, allergy or inflammatory conditions. Screening assays for identifying these agonists and antagonist compounds are also provided.


Find Patent Forward Citations

Loading…